share_log

Allena Pharmaceuticals (ALNAQ) Set to Announce Earnings on Tuesday

Allena Pharmaceuticals (ALNAQ) Set to Announce Earnings on Tuesday

艾伦娜制药（ALNAQ）定于周二公布财报
Financial News Live ·  2022/11/07 23:01

Allena Pharmaceuticals (NASDAQ:ALNAQ – Get Rating) is set to announce its earnings results on Tuesday, November 8th.

Allena Pharmicals（纳斯达克股票代码：ALNAQ — 获取评级）定于11月8日星期二公布其财报。

Allena Pharmaceuticals Stock Performance

艾伦娜制药股票表现

Shares of Allena Pharmaceuticals stock remained flat at $0.01 on Monday. The stock had a trading volume of 363,247 shares, compared to its average volume of 12,972,626. The company's 50-day moving average is $0.02. Allena Pharmaceuticals has a 12 month low of $0.01 and a 12 month high of $1.00.

周一，艾伦娜制药的股价持平至0.01美元。该股的交易量为363,247股，而平均交易量为12,972,626股。该公司的50天移动平均线为0.02美元。艾伦娜制药创下12个月低点0.01美元，12个月高点为1.00美元。

Get
获取
Allena Pharmaceuticals
艾伦娜制药
alerts:
警报：

About Allena Pharmaceuticals

关于艾伦娜制药

(Get Rating)

（获取评分）

Allena Pharmaceuticals, Inc, a biopharmaceutical company, discovers, develops, and commercializes oral enzyme therapeutics to treat patients with rare and severe metabolic, and kidney disorders in the United States. Its lead product candidate is ALLN-346, a novel and urate degrading enzyme for patients with hyperuricemia and gout in the setting of advanced chronic kidney disease.
Allena Pharmicals, Inc是一家生物制药公司，在美国发现、开发和商业化口服酶疗法，用于治疗患有罕见和严重代谢和肾脏疾病的患者。其主要候选产品是 ALLN-346，这是一种新型的尿酸盐降解酶，适用于晚期慢性肾脏病背景下的高尿酸血症和痛风患者。

Read More

阅读更多

  • Get a free copy of the StockNews.com research report on Allena Pharmaceuticals (ALNAQ)
  • Bulls Vs Bears: Mullen Automotive Short Interest Grows
  • Palantir Falls Into The Hands Of Value Investors
  • The Analysts Can't Keep Up with Arista Networks Stock
  • 3 Reasons Amazon Will Deliver Better 2023 Returns
  • A Turnaround is Brewing in Starbucks Stock
  • 免费获取 StockNews.com 关于艾伦娜制药（ALNAQ）的研究报告的副本
  • 牛市与熊市：马伦汽车空头利率增加
  • Palantir 落入价值投资者手中
  • 分析师跟不上 Arista Networks 股票的步伐
  • 亚马逊将在 2023 年提供更好退货的 3 个理由
  • 星巴克股票正在酝酿转机

Receive News & Ratings for Allena Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allena Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.

接收《艾伦娜制药日报》的新闻和评级 -在下面输入您的电子邮件地址，即可通过Marketbeat.com的免费每日电子邮件时事通讯接收Allena Pharmicals及相关公司的最新新闻和分析师评级的简明每日摘要。

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发